While HSA synthesis is indeed reduced due to liver disease or injury, even in a setting of extremely high aflatoxin exposure (e.g., 1 μg/day), HSA is present in the liver at a molar ratio of roughly 100,000:1 relative to AFB1 (see Appendix A). The gene discussed is ALB; the disease is liver disorder.